Vir Biotechnology, Inc. VIR License and collaboration revenue — Total revenues
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Vir Biotechnology, Inc. in its filing.
Tagged under the XBRL concept us-gaap:Revenues.
The official record: Vir Biotechnology, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Vir Biotechnology, Inc.'s license and collaboration revenue — total revenues.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Vir Biotechnology, Inc.'s license and collaboration revenue — total revenues?
- Vir Biotechnology, Inc. (VIR) reported license and collaboration revenue — total revenues of -$41K in Q1 2026.
- How has Vir Biotechnology, Inc.'s license and collaboration revenue — total revenues changed year-over-year?
- Vir Biotechnology, Inc.'s license and collaboration revenue — total revenues increased by 41.4% year-over-year, from -$70K to -$41K.
- What does license and collaboration revenue — total revenues mean?
- This metric represents the total revenue generated from licensing intellectual property and entering into strategic research or development collaborations with third-party partners. It reflects the company's ability to monetize its proprietary technology platforms and pipeline assets through external partnerships rather than solely through direct product sales. This revenue stream is a critical indicator of the company's success in validating its scientific platforms and securing non-dilutive capital to fund ongoing research and development activities.